JCEM :糖尿病的家族病史是否影响母亲和胎儿血管循环和炎症反应?

2017-06-26 MedSci MedSci原创

糖尿病的遗传可能性与高胰岛素血症、血管内皮功能受损和炎症性的上调有关。然而,没有研究调查糖尿病家族病史是否影响胎盘血管循环。此研究旨在探讨2型糖尿病(FHD)的一级家族病史对胎盘血管循环及炎性病变的影响。

背景:
糖尿病的遗传可能性与高胰岛素血症、血管内皮功能受损和炎症性的上调有关。然而,没有研究调查糖尿病家族病史是否影响胎盘血管循环。

目的:
此研究旨在探讨2型糖尿病(FHD)的一级家族病史对胎盘血管循环及炎性病变的影响。

方法:
采用观察性队列研究,招募了来自在Edith Wolfson医疗中心分娩的339名孕妇。根据是否存在FHD,将其分成两组:第一组包括225名无FHD的受试者,第2组则包括114名FHD的受试者。干预措施:胎盘组织病理学检查。主要结果测量:母体和胎儿的胎盘血管供应异常。

结果:
与无FHD的研究对象相比,FHD患者胎盘的母体血管供血(MVS)明显异常(p<0.005)。关于胎儿血管供应(FVS)异常,以及母体和胎儿炎症反应,在两组间没有明显差异。在GLM分析中,FHD是MVS异常的独立和重要的预测因子,其风险增加了一倍多。在FHD的受试者中,妊娠期糖尿病发病率明显较高(p<0.0001)。即使在对年龄和BMI进行调整后,妊娠期糖尿病的显着的组别差异仍然存在。尽管在FHD患者中,妊娠期高血压患者的发生率明显较高,但在调整后,FHD并没有显着地预测这一结果。

结论:
一级2型糖尿病(FHD)与母体血管循环异常和妊娠期糖尿病风险的增加密切相关。

原始出处

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1812314, encodeId=695a181231448, content=<a href='/topic/show?id=a11989638d8' target=_blank style='color:#2F92EE;'>#血管循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89638, encryptionId=a11989638d8, topicName=血管循环)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 19 02:04:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062997, encodeId=07c0206299e80, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Sep 19 23:04:00 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777615, encodeId=bacd1e77615b1, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Aug 20 09:04:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224484, encodeId=643922448455, content=学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Fri Jul 21 07:10:09 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320834, encodeId=2a09132083435, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 28 05:04:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1812314, encodeId=695a181231448, content=<a href='/topic/show?id=a11989638d8' target=_blank style='color:#2F92EE;'>#血管循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89638, encryptionId=a11989638d8, topicName=血管循环)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 19 02:04:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062997, encodeId=07c0206299e80, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Sep 19 23:04:00 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777615, encodeId=bacd1e77615b1, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Aug 20 09:04:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224484, encodeId=643922448455, content=学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Fri Jul 21 07:10:09 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320834, encodeId=2a09132083435, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 28 05:04:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-09-19 achengzhao
  3. [GetPortalCommentsPageByObjectIdResponse(id=1812314, encodeId=695a181231448, content=<a href='/topic/show?id=a11989638d8' target=_blank style='color:#2F92EE;'>#血管循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89638, encryptionId=a11989638d8, topicName=血管循环)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 19 02:04:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062997, encodeId=07c0206299e80, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Sep 19 23:04:00 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777615, encodeId=bacd1e77615b1, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Aug 20 09:04:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224484, encodeId=643922448455, content=学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Fri Jul 21 07:10:09 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320834, encodeId=2a09132083435, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 28 05:04:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-08-20 smallant2015
  4. [GetPortalCommentsPageByObjectIdResponse(id=1812314, encodeId=695a181231448, content=<a href='/topic/show?id=a11989638d8' target=_blank style='color:#2F92EE;'>#血管循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89638, encryptionId=a11989638d8, topicName=血管循环)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 19 02:04:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062997, encodeId=07c0206299e80, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Sep 19 23:04:00 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777615, encodeId=bacd1e77615b1, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Aug 20 09:04:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224484, encodeId=643922448455, content=学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Fri Jul 21 07:10:09 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320834, encodeId=2a09132083435, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 28 05:04:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]
    2017-07-21 lofter

    学习了,感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1812314, encodeId=695a181231448, content=<a href='/topic/show?id=a11989638d8' target=_blank style='color:#2F92EE;'>#血管循环#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89638, encryptionId=a11989638d8, topicName=血管循环)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat May 19 02:04:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062997, encodeId=07c0206299e80, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Tue Sep 19 23:04:00 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777615, encodeId=bacd1e77615b1, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Aug 20 09:04:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224484, encodeId=643922448455, content=学习了,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Fri Jul 21 07:10:09 CST 2017, time=2017-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320834, encodeId=2a09132083435, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 28 05:04:00 CST 2017, time=2017-06-28, status=1, ipAttribution=)]

相关资讯

Exp Physiol:如何预防胰岛素抵抗与随之而来的糖尿病?

近期,上海交通大学药学院李大伟教授课题组经过多年研究在肿瘤治疗新靶点研究方面取得重大突破,其研究揭示了乳腺癌中高表达的人前梯度蛋白 2(AGR2)在肿瘤发生发展中的新作用机制。同时,根据相关机制开发的人源化抗体药物 Agtuzumab(18A4Hu)在抗肿瘤及药物联用方面也表现出了优良的治疗效果,相关的一系列研究发表在今年 5 月 8 日的 Nature 子刊《Oncogene》上以及 2016

Autophagy:科研人员揭示糖尿病中枢神经系统病变新机制

6月20日,Autophagy 杂志在线发表了中国科学院生物物理研究所研究员陈畅课题组题为 Autophagy impairment mediated by S-nitrosation of ATG4B leads to neurotoxicity in response to hyperglycemia 的研究论文,揭示了 ATG4B 亚硝基化修饰介导的自噬缺陷在糖尿病中枢神经病变中的作用。

SCI REP:定期运动改善糖尿病患者基因组稳定性!

最后,针对T2DM患者基因表达分析表明适应性反应延长的运动训练可以提高特定基因的反应。

Sci Rep:科学家发明预防糖尿病“神器”,帮助人类摆脱糖尿病!

来自得克萨斯大学的研究人员开发出一种可穿戴的生物传感器,能够检测出引起糖尿病的三种关联化合物,分别为皮质醇,葡萄糖和白细胞介素- 6,研究人员大胆设想,如果将这一传感器连接手机,那么就可以实时监控糖尿病的变化。

Diabetic Med:1991年至2013年英国Ⅱ型糖尿病患病率,血糖控制和相对生存率如何?

近日,国际杂志《Diabetic medicine》上在线发表1991年至2013年英国2型糖尿病患病率,血糖控制和相对生存率,并确定在此期间糖尿病患者的相应葡萄糖控制和存活率是否发生变化。

Circulation:糖尿病患者血小板表达活化的P2Y12受体

血小板P2Y12受体表达显著增加,在T2DM患者中该受体被结构性激活,这导致血小板机能亢进并限制了T2DM中抗血小板药物的疗效。